Effect of Levosimendan on miRNAs Regulation in the Failing Hearts
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 136 participants.
Also called NCT04950569
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 136 participants
- Sponsor
- Registry
-
NCT04950569
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04950569. Randomized; no masking; primary purpose treatment. Start 2020-10-29 (actual); primary completion 2022-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Levosimendan on miRNAs Regulation in the Failing Hearts
- Condition
- Heart Failure
- Intervention (Drug)
- levosimendan
- Lead sponsor
- Tongji Hospital
Record details
- Record id
cardio:ct-nct04950569- Content hash
c8a2ad066b4782a21f4f1e883e2bace36a8deebaa0a46447935f7238cb0b4009